<DOC>
	<DOC>NCT01431404</DOC>
	<brief_summary>The purpose of this study is compare the safety and pharmacokinetic characteristics of HD203 liquid with those of etanercept (enbrel) prefilled injection after subcutaneous injection.</brief_summary>
	<brief_title>Safety and Pharmacokinetic Characteristics of HD203 Liq. in Healthy Subjects</brief_title>
	<detailed_description>A randomized, double-blind, single-dosing, crossover study to compare the safety and pharmacokinetic characteristics of HD203 Liquid 25 mg with those of Enbrel PrefilledÂ® injection 25 mg after subcutaneous injection.</detailed_description>
	<mesh_term>Etanercept</mesh_term>
	<criteria>20 to 40 years of healthy volunteers Weight over 55kg Subject who signed on ICF Subject who had been treated with Etanercept before</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>